CMS Eliminates Outdated Rules, Projects Provider Savings of $660M a Year

Final rule reduces burdens to critical access hospitals, rural clinics; loosens physician supervision requirements.
Published Online: May 09, 2014

Hospitals will save approximately $660 million a year thanks to a new government rule that removes unnecessary, obsolete or burdensome regulations, according to the Centers for Medicare & Medicaid Services (CMS).

The reforms, announced yesterday in a final rule, eliminates requirements that hinder hospitals or other healthcare organizations from providing high-quality patient care, the agency said in an announcement. CMS estimates organizations will save roughly $3.2 billion over the next five years as a result of the new rule. In addition, it projects that combined with President Barack Obama's "regulatory look-back" executive order, the two rules will save healthcare providers $8 million over the course of five years.

"By eliminating stumbling blocks and red tape we can assure that the healthcare that reaches patients is more timely, that it's the right treatment for the right patient, and greater efficiency improves patient care across the board," said CMS Administrator Marilyn Tavenner in the announcement.

Read the full story here: http://bit.ly/1qmiASE

Source: Fierce Healthcare


Feature
Recommended Articles
The deal combines Humana's 3.2 million Medicare enrollees with Aetna's 1.26 million Medicare enrollees, giving the new combined company a strong position as the baby boomer population ages.
As co-pays and deductibles in Medicare and commercial health plans become more prevalent, so, too, does the temptation to waive them. But beware.
In addition to increasing insurance coverage, the Affordable Care Act also aims to improve population health and lower healthcare costs. However, not much attention has been paid to the quality of care the newly insured are receiving.
The UK government has come up with an innovative plan to increase public awareness of the increasing price of prescription drugs and what it costs the healthcare system
During this one-on-one interview, a part of the Oncology Stakeholders Summit, Spring 2015 series, Michael Kolodziej, MD, discusses payer considerations regarding coverage for new cancer treatments such as immuno-oncology therapies.